Influenza enzyme and zanamivir drug

Influenza enzyme and zanamivir drug

C026/6015 Rights Managed

Request low-res file

530 pixels on longest edge, unwatermarked

Request/Download high-res file

Uncompressed file size: 50.0MB

Downloadable file size: 2.2MB

Price image Pricing

Please login to use the price calculator


Caption: Influenza enzyme and zanamivir drug. Molecular model of the neuraminidase glycoprotein enzyme from the surface of the influenza A virus, bound to the drug zanamivir. The function of this protein is to enable the flu virus to be released from the host cell. Zanamivir, marketed as Relenza, is a neuraminidase inhibitor. This enzyme is from the H1N1 strain of the flu virus.

Release details: Model release not required. Property release not required.

Keywords: artwork, biochemical, biochemistry, biological, biology, biomolecule, condition, cut out, cut outs, cut-out, cut-outs, cutout, cutouts, disease, disorder, drug, enzyme, flu, glycoprotein, graphic, h1n1, illustration, influenza a, macromolecule, medical, medicine, molecular biology, molecular model, molecular structure, molecules, neuraminidase, no-one, nobody, pharmaceutical, pharmaceutics, pharmacological, pharmacology, protein, proteins, proteomics, structural, treatment, virus, white background, zanamivir

Licence fees: A licence fee will be charged for any media (low or high resolution) used in your project.